CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 301–400번째 · 4 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100109BBiotinylated Anti-B7-H5(onvatilimab biosimilar) mAb
  2. BME100109PPE-conjugated Anti-B7-H5(onvatilimab biosimilar) mAb
  3. BME100110Anti-TLR2(tomaralimab biosimilar) mAb
  4. BME100110BBiotinylated Anti-TLR2(tomaralimab biosimilar) mAb
  5. BME100110PPE-conjugated Anti-TLR2(tomaralimab biosimilar) mAb
  6. BME100111Anti-LRRC15(samrotamab biosimilar) mAb
  7. BME100111BBiotinylated Anti-LRRC15(samrotamab biosimilar) mAb
  8. BME100111PPE-conjugated Anti-LRRC15(samrotamab biosimilar) mAb
  9. BME100112Anti-TSLP(tezepelumab biosimilar) mAb
  10. BME100112BBiotinylated Anti-TSLP(tezepelumab biosimilar) mAb
  11. BME100112PPE-conjugated Anti-TSLP(tezepelumab biosimilar) mAb
  12. BME100113Anti-LIV-1(ladiratuzumab biosimilar) mAb
  13. BME100113BBiotinylated Anti-LIV-1(ladiratuzumab biosimilar) mAb
  14. BME100114Anti-IL22(fezakinumab biosimilar) mAb
  15. BME100114BBiotinylated Anti-IL22(fezakinumab biosimilar) mAb
  16. BME100114PPE-conjugated Anti-IL22(fezakinumab biosimilar) mAb
  17. BME100115Anti-CCR8(BMS 986340) mAb
  18. BME100115BBiotinylated Anti-CCR8(BMS 986340) mAb
  19. BME100115PPE-conjugated Anti-CCR8(BMS 986340) mAb
  20. BME100116Anti-IL1B(canakinumab biosimilar) mAb
  21. BME100116BBiotinylated Anti-IL1B(canakinumab biosimilar) mAb
  22. BME100116PPE-conjugated Anti-IL1B(canakinumab biosimilar) mAb
  23. BME100117Anti-IFNAR1(anifrolumab biosimilar) mAb
  24. BME100117BBiotinylated Anti-IFNAR1(anifrolumab biosimilar) mAb
  25. BME100117PPE-conjugated Anti-IFNAR1(anifrolumab biosimilar) mAb
  26. BME100118Anti-MST1R(narnatumab biosimilar) mAb
  27. BME100118BBiotinylated Anti-MST1R(narnatumab biosimilar) mAb
  28. BME100119Anti-NRP1(vesencumab biosimilar) mAb
  29. BME100119BBiotinylated Anti-NRP1(vesencumab biosimilar) mAb
  30. BME100119PPE-conjugated Anti-NRP1(vesencumab biosimilar) mAb
  31. BME100120Anti-C5AR1(avdoralimab biosimilar) mAb
  32. BME100120BBiotinylated Anti-C5AR1(avdoralimab biosimilar) mAb
  33. BME100120PPE-conjugated Anti-C5AR1(avdoralimab biosimilar) mAb
  34. BME100121Anti-ITGB7(vedolizumab biosimilar) mAb
  35. BME100122Anti-IL9(enokizumab biosimilar) mAb
  36. BME100122BBiotinylated Anti-IL9(enokizumab biosimilar) mAb
  37. BME100122PPE-conjugated Anti-IL9(enokizumab biosimilar) mAb
  38. BME100123Anti-KLK3(lanadelumab biosimilar) mAb
  39. BME100124Anti-CD142(tisotumab biosimilar) mAb
  40. BME100124BBiotinylated Anti-CD142(tisotumab biosimilar) mAb
  41. BME100124PPE-conjugated Anti-CD142(tisotumab biosimilar) mAb
  42. BME100125Anti-CCL2(carlumab biosimilar) mAb
  43. BME100125BBiotinylated Anti-CCL2(carlumab biosimilar) mAb
  44. BME100125PPE-conjugated Anti-CCL2(carlumab biosimilar) mAb
  45. BME100127Anti-SSTR2(tidutamab biosimilar) mAb
  46. BME100127BBiotinylated Anti-SSTR2(tidutamab biosimilar) mAb
  47. BME100127PPE-conjugated Anti-SSTR2(tidutamab biosimilar) mAb
  48. BME100128Anti-PSMA(rosopatamab biosimilar) mAb
  49. BME100128BBiotinylated Anti-PSMA(rosopatamab biosimilar) mAb
  50. BME100128PPE-conjugated Anti-PSMA(rosopatamab biosimilar) mAb
  51. BME100129Anti-CD73(uliledlimab biosimilar) mAb
  52. BME100129BBiotinylated Anti-CD73(uliledlimab biosimilar) mAb
  53. BME100129PPE-conjugated Anti-CD73(uliledlimab biosimilar) mAb
  54. BME100130Anti-GM-CSF(plonmarlimab biosimilar) mAb
  55. BME100130BBiotinylated Anti-GM-CSF(plonmarlimab biosimilar) mAb
  56. BME100130PPE-conjugated Anti-GM-CSF(plonmarlimab biosimilar) mAb
  57. BME100131Anti-FLT1(icrucumab biosimilar) mAb
  58. BME100131BBiotinylated Anti-FLT1(icrucumab biosimilar) mAb
  59. BME100131PPE-conjugated Anti-FLT1(icrucumab biosimilar) mAb
  60. BME100132Anti-IL20(fletikumab biosimilar) mAb
  61. BME100132BBiotinylated Anti-IL20(fletikumab biosimilar) mAb
  62. BME100132PPE-conjugated Anti-IL20(fletikumab biosimilar) mAb
  63. BME100133Anti-CXCL10(eldelumab biosimilar) mAb
  64. BME100133BBiotinylated Anti-CXCL10(eldelumab biosimilar) mAb
  65. BME100133PPE-conjugated Anti-CXCL10(eldelumab biosimilar) mAb
  66. BME100134Anti-KIR2DL2(lirilumab biosimilar) mAb
  67. BME100134BBiotinylated Anti-KIR2DL2(lirilumab biosimilar) mAb
  68. BME100134PPE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb
  69. BME100136Anti-APP(aducanumab biosimilar) mAb
  70. BME100136BBiotinylated Anti-APP(aducanumab biosimilar) mAb
  71. BME100136PPE-conjugated Anti-APP(aducanumab biosimilar) mAb
  72. BME100137Anti-IL17A(secukinumab biosimilar) mAb
  73. BME100137BBiotinylated Anti-IL17A(secukinumab biosimilar) mAb
  74. BME100137PPE-conjugated Anti-IL17A(secukinumab biosimilar) mAb
  75. BME100138Anti-TFRC(pabinafusp alfa biosimilar) mAb
  76. BME100138BBiotinylated Anti-TFRC(pabinafusp alfa biosimilar) mAb
  77. BME100138PPE-conjugated Anti-TFRC(pabinafusp alfa biosimilar) mAb
  78. BME100139Anti-HGF(ficlatuzumab biosimilar) mAb
  79. BME100139BBiotinylated Anti-HGF(ficlatuzumab biosimilar) mAb
  80. BME100139PPE-conjugated Anti-HGF(ficlatuzumab biosimilar) mAb
  81. BME100140Anti-CD3E(DIMA BM323) mAb
  82. BME100140BBiotinylated Anti-CD3E(DIMA BM323) mAb
  83. BME100140PPE-conjugated Anti-CD3E(DIMA BM323) mAb
  84. BME100141Anti-IFNG(emapalumab biosimilar) mAb
  85. BME100141BBiotinylated Anti-IFNG(emapalumab biosimilar) mAb
  86. BME100141PPE-conjugated Anti-IFNG(emapalumab biosimilar) mAb
  87. BME100142Anti-GCGR(volagidemab biosimilar) mAb
  88. BME100142BBiotinylated Anti-GCGR(volagidemab biosimilar) mAb
  89. BME100142PPE-conjugated Anti-GCGR(volagidemab biosimilar) mAb
  90. BME100143Anti-MASP2(narsoplimab biosimilar) mAb
  91. BME100143BBiotinylated Anti-MASP2(narsoplimab biosimilar) mAb
  92. BME100143PPE-conjugated Anti-MASP2(narsoplimab biosimilar) mAb
  93. BME100144Anti-IL13(tralokinumab biosimilar) mAb
  94. BME100145Anti-LILRB2 (MK-4830) mAb
  95. BME100145BBiotinylated Anti-LILRB2 (MK-4830) mAb
  96. BME100145PPE-conjugated Anti-LILRB2 (MK-4830) mAb
  97. BME100146Anti-ITGAV(abituzumab biosimilar) mAb
  98. BME100146BBiotinylated Anti-ITGAV(abituzumab biosimilar) mAb
  99. BME100146PPE-conjugated Anti-ITGAV(abituzumab biosimilar) mAb
  100. BME100147Anti-GPC3(Hu9F2) mAb